Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — Italian researchers recently confirmed that subacromial decompression has no significant ...

Subacromial decompression does not significantly influence functional outcomes after the arthroscopic repair of full-thickness rotator cuff tears, according to results of a prospective study by ...

POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...

Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...

Many countries have strict regulations to ensure new drugs are effective and are worth the money before doctors can prescribe them. But surgical procedures are often less strictly regulated. This can ...

Common surgery given to thousands of patients battling shoulder pain doesn't work, according to mounting evidence. Decompression surgery is used to manage the symptoms of the most common form of ...

The revision of CPT 29826 from a standalone code to an add-on code — +29826 (Arthroscopy, shoulder, surgical; decompression of subacromial space with partial acromioplasty, with coracoacromial ...

Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site. Posimir ® (bupivacaine solution) is now available for ...

A new study claims patients undergoing one of the most common surgical procedures in the western world might be wasting their time. A team of researchers from the University of Helsinki has spent the ...

Many countries have strict regulations to ensure new drugs are effective and are worth the money before doctors can prescribe them. But surgical procedures are often less strictly regulated. This can ...

CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for ...

Many countries have strict regulations to ensure new drugs are effective and are worth the money before doctors can prescribe them. But surgical procedures are often less strictly regulated. This can ...